Evidence map›Paper›PMID 39840556›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Combining Hard Shell with Soft Core to Enhance Enzyme Activity and Resist External Disturbances.

Yiwen Wang, Hongfei Tong, Shulan Ni, Kaiyuan Huo, Wenjie Liu, Xingjie Zan, Xiaodie Yuan, Shuangshuang Wang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Reticular Chemistry: A Versatile Platform for Engineering Heterogenous Biocatalysts.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yiwen WangDepartment of Cardiology, The First People's Hospital of Wenling, Wenling Hospital of Wenzhou Medical University, Wenling, Zhejiang, 317500, China.
Hongfei TongYongkang First People's Hospital of Wenzhou Medical University, Jinhua, Zhejiang, China.
Shulan NiDepartment of Cardiology, The First People's Hospital of Wenling, Wenling Hospital of Wenzhou Medical University, Wenling, Zhejiang, 317500, China.
Kaiyuan HuoDepartment of Cardiology, The First People's Hospital of Wenling, Wenling Hospital of Wenzhou Medical University, Wenling, Zhejiang, 317500, China.
Wenjie LiuWenzhou Institute, University of Chinese Academy of Sciences, Wenzhou Key Laboratory of Perioperative Medicine, Wenzhou, Zhejiang, 325001, China.
Xingjie ZanWenzhou Institute, University of Chinese Academy of Sciences, Wenzhou Key Laboratory of Perioperative Medicine, Wenzhou, Zhejiang, 325001, China.ORCID https://orcid.org/0000-0002-0492-2913
Xiaodie YuanWenzhou Institute, University of Chinese Academy of Sciences, Wenzhou Key Laboratory of Perioperative Medicine, Wenzhou, Zhejiang, 325001, China.
Shuangshuang WangDepartment of Cardiology, The First People's Hospital of Wenling, Wenling Hospital of Wenzhou Medical University, Wenling, Zhejiang, 317500, China.

Funding

Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province 2022E10026Social Development Science and Technology Foundation of Taizhou and Wenling 2021S00197Social Development Science and Technology Foundation of Taizhou and Wenling 21ywb115Wenzhou Institute of UCAS WIUCASQD2019009Zhejiang Provincial Program for Medicine and Health 2023KY411Zhejiang Provincial Program for Medicine and Health 2025KY1880
6 · The paper itself

Abstract

Immobilizing enzymes onto solid supports having enhanced catalytic activity and resistance to harsh external conditions is considered as a promising and critical method of broadening enzymatic applications in biosensing, biocatalysis, and biomedical devices; however, it is considerably hampered by limited strategies. Here, a core-shell strategy involving a soft-core hexahistidine metal assembly (HmA) is innovatively developed and characterized with encapsulated enzymes (catalase (CAT), horseradish peroxidase, glucose oxidase (GOx), and cascade enzymes (CAT+GOx)) and hard porous shells (zeolitic imidazolate framework (ZIF), ZIF-8, ZIF-67, ZIF-90, calcium carbonate, and hydroxyapatite). The enzyme-friendly environment provided by the embedded HmA proves beneficial for enhanced catalytic activity, which is particularly effective in preserving fragile enzymes that will have been deactivated without the HmA core during the mineralization of porous shells. The enzyme encapsulated within a core-shell particle exhibits noteworthy resilience against harsh external conditions, including heat, organic solvents, and proteinase K. Additionally, no significant alteration in the catalytic behavior of the enzyme is observed after multiple cycles of usage. This study offers a novel approach for immobilizing enzymes and rendering them resistant to harsh external conditions, with potential applications in diverse fields, including biocatalysis, bioremediation, and biomedical engineering.

Indexed as

Enzymes, ImmobilizedBiocatalysisGlucose OxidaseHorseradish PeroxidaseMetal-Organic FrameworksPorosityEnzymes, ImmobilizedGlucose OxidaseHorseradish PeroxidaseMetal-Organic Frameworkscatalysiscore–shell structureenzyme immobilizationhexahistidine metal assembly (HmA)zeolitic imidazolate framework (ZIF)

Identifiers

PMID39840556
PMCPMC11905098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.